Track 16: Diabetes Gene Therapy

New approaches to the treatment and cure of type 1 diabetes may be developed as a result of recent advances in molecular and cell biology. In instance, the restoration of insulin secretion through gene or cell-replacement treatment can currently be predicted. Over 180 million individuals worldwide are affected with diabetes mellitus, which is on the rise. The majority of cases of diabetes are type 2, and by 2030, the incidence is anticipated to have more than quadrupled due to the ageing population expansion and sharp rise in obesity prevalence.


    Related Conference of Track 16: Diabetes Gene Therapy

    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    August 28-29, 2025

    12th World Congress on Epigenetics and Chromosome

    London, UK
    September 16-17, 2025

    5th Experts Meeting on Plant, Cellular and Molecular Biology

    Madrid, Spain
    September 25-26, 2025

    18th World Congress on Advances in Stem Cell Research and Regenerative Medicine

    Montreal, Canada
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain
    October 30-31, 2025

    Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

    Rome, Italy
    November 17-18, 2025

    18th International Conference on Human Genomics and Genomic Medicine

    Paris, France
    June 18-19, 2026

    16th International Conference on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Track 16: Diabetes Gene Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in